Family Study of Lymphoproliferative Disorders
| Status: | Recruiting |
|---|---|
| Conditions: | Blood Cancer, Lymphoma, Hematology, Hematology, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 4/25/2018 |
| Start Date: | April 2004 |
| End Date: | July 2020 |
| Contact: | Catie Erding |
| Email: | Erding.Catherine@mayo.edu |
| Phone: | 1-855-899-0693 |
Genetic Epidemiology of Lymphoproliferative Disorders
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of
lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved
with the uncontrolled growth of white blood cells. There are many subtypes of these cancers,
e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that
these cancers cluster in families, this study aims to understand how genetics and
environmental exposures contribute to the development of these cancers.
lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved
with the uncontrolled growth of white blood cells. There are many subtypes of these cancers,
e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that
these cancers cluster in families, this study aims to understand how genetics and
environmental exposures contribute to the development of these cancers.
At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
We found this trial at
1
site
Rochester, Minnesota 55905
Principal Investigator: Susan L Slager, PhD
Phone: 855-776-0015
Click here to add this to my saved trials
